Area of research
Immunology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Immune cells in cancer, and Brain Metastases and Treatment.
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities
Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti‐PD‐1 antibodies
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
Melanoma central nervous system metastases: current approaches, challenges, and opportunities
Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy